ArrhythmiaNCT07123896
Arrhythmia Cohort Study
An observational study of Arrhythmia, run by Beijing Anzhen Hospital at 1 site in China.
Trial summary
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation… Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Arrhythmia
- What is being tested?
- Normal treatment with catheter ablation or medicine and Drug Treatment
- Type of treatment
- Medical device
- How many people
- 10,000 participants
- Where
- 1 siteChina
- Study dates
- 24 Aug 2025to 24 Jul 2030
- How long will I take part?
- 5 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Adult, Older adult
Study population: Patients hospitalized for various types of arrhythmia
Who may be able to join
- Patients hospitalized for any type of arrhythmia
Who cannot join
- Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
Deyong Long
Beijing
Deyong Long, Doctor, +86 13522958166, dragon2008@vip.sina.com
About this study
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
- Conditions
- Arrhythmia
- Being tested
- Normal treatment with catheter ablation or medicine, Drug Treatment
- Medical subject headings
- Arrhythmias, Cardiac
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Normal treatment with catheter ablation or medicineDevice
Routine clinical care with catheter ablation and/or medicine; real-world clinical cases
Drug TreatmentDrug
Routine clinical care with medicine; real-world clinical cases
| Study group | Role | What they receive |
|---|---|---|
| Treatment | Not described Receives: Device: Normal treatment with catheter ablation or medicine; Drug: Drug Treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Arrhythmia recurrence
Recurrence of the arrhythmia after treatment
Measured: 1 year
All-cause death
Death due to any reason
Measured: 1 year
Secondary outcomes (8)
Arrhythmia recurrence
Recurrence of the arrhythmia after treatment
Measured: 5 year
All-cause death
Death due to any reason
Measured: 5 year
Cardiovascular death
Death due to cardiovascular disease
Measured: 1 year
Cardiovascular death
Death due to cardiovascular disease
Measured: 5 year
Heart failure
Heart failure due to cardiovascular disease
Measured: 1 year
Heart failure
Heart failure due to cardiovascular disease
Measured: 5 year
Cardiovascular hospitalization
Hospitalization due to cardiovascular disease
Measured: 1 year
Cardiovascular hospitalization
Hospitalization due to cardiovascular disease
Measured: 5 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2025
- Study start24 Aug 2025 (estimated)
- Primary completion24 Jul 2030 (estimated)
- Study completion24 Jul 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ArrhythmiaStudies of the same condition, open and under way.
- More trials run by Beijing Anzhen HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Beijing Anzhen Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07123896
- Sponsor's protocol ID
- KS2025136
- Status last verified
- Aug 2025
- First submitted
- 29 Jul 2025
- Last updated
- 14 Aug 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- Yes
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 14 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Arrhythmia Cohort Study
- ClinicalTrials.gov ID
- NCT07123896
- Acronym / sponsor ID
- KS2025136
- Conditions
- Arrhythmia
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- Beijing Anzhen HospitalUniversity, hospital or other
- Study start
- 24 Aug 2025 (estimated)
- Primary completion
- 24 Jul 2030 (estimated)
- Study completion
- 24 Jul 2030 (estimated)
- First posted
- 14 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 5 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Treatment | – | Device: Normal treatment with catheter ablation or medicine, Drug: Drug Treatment |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients hospitalized for various types of arrhythmia
Key inclusion criteria (1 listed)
- Patients hospitalized for any type of arrhythmia
Key exclusion criteria (1 listed)
- Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Normal treatment with catheter ablation or medicineRoutine clinical care with catheter ablation and/or medicine; real-world clinical cases | Device | Treatment |
| Drug TreatmentRoutine clinical care with medicine; real-world clinical cases | Drug | Treatment |
Primary outcome
Arrhythmia recurrence
Time frame: 1 year
Recurrence of the arrhythmia after treatment
All-cause death
Time frame: 1 year
Death due to any reason
8 secondary outcomes
Arrhythmia recurrence
Time frame: 5 year
All-cause death
Time frame: 5 year
Cardiovascular death
Time frame: 1 year
Cardiovascular death
Time frame: 5 year
Heart failure
Time frame: 1 year
Heart failure
Time frame: 5 year
Cardiovascular hospitalization
Time frame: 1 year
Cardiovascular hospitalization
Time frame: 5 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Aug 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Arrhythmia
Active, not recruiting
VOLT CE Mark Study
Atrial Arrhythmia, Atrial Fibrillation
Enrolling by invitation
EDEN Intracardiac Electrogram Recording and Classifying System
Ventricular Arrhythmia
RecruitingObservational study
Southeast Asian Brugada Syndrome Cohort
Brugada Syndrome
Enrolling by invitation
VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms) Using Commercial Off-The-Shelf (COTS) Catheters
Ventricular Arrhythmia
Recruiting
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Tachycardia, Ventricular
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arrhythmia, run by Beijing Anzhen Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 14 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Arrhythmia recurrence (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2025.